Omega
USA
Home Products Sponsored riders Educational section Stores Contact Us

PRODUCTS CATEGORIES

 

Events and News


Kachemak Bay Named Omega Alpha Canadian Event Horse of the Month for May

June 15, 2009 — The Canadian Eventing Committee has named Kachemak Bay as Omega Alpha Canadian Event Horse of the Month for May.

Kachemak Bay, Frankie Simpson’s 15-year-old Canadian Thoroughbred gelding, finished as the top Canadian entry, in fourth place, at the 2009 edition of the Jersey Fresh CCI 3* Three Day Event, held May 7–10, 2009, in Allentown, New Jersey, USA.

Ridden by Karl Slezak of Tottenham, ON, Kachemak Bay was tied for 20th place after dressage with a score of 63.4. Adding only 4.4 cross country time faults following a flawlessly ridden performance over John Williams’ (USA) cross country course, Slezak and Kachemak Bay leaped up the leaderboard to fourth place. A clean ride in the show jumping round kept the pair in fourth place, finishing on a score of 67.8.

“I'm so proud of both Kachemak Bay (Zeus) and Karl. They really are a fantastic team, and I am so pleased with their results this year,” said Simpson, who lives in Orangeville, ON. “Zeus is a really cool little horse with a larger than life personality, and he really does live to event. Hopefully the pair will have many great things to come. I'd like to give a big thank you to Omega Alpha and the Canadian Eventing Committee for recognizing these fantastic horses every month. This award is a really nice gesture to the horses, riders and owners.”

Canadian Eventing created the horse recognition program to celebrate the achievements of Canadian owned horses that represent Canada in North American competition. Canadian Eventing is also very pleased to have Omega Alpha Pharmaceuticals’ generous support of this new horse recognition program. Omega Alpha Pharmaceuticals will be providing each owner of the "Horse of the Month" with a generous gift certificate of $200 credit towards the purchase of Omega Alpha products of their choice.

About Canadian Eventing

Canadian Eventing is the committee of Equine Canada responsible for the sport of eventing in Canada from the grassroots to the international level. The Canadian Eventing Committee is comprised of 12 members, including two rider representatives elected by the Elite Riders Association. Directed by the Strategic Plan for Eventing, all Eventing activities are administered by this committee via six sub-committees with the support of an eventing manager based at the Equine Canada office in Ottawa. For more information about Canadian Eventing, visit www.equinecanada.ca and select disciplines then Eventing.

About Omega Alpha Pharmaceuticals Inc.

Omega Alpha Pharmaceuticals Inc. is Canadian owned and incorporated in 1992, and with the approval of Health Canada, Omega Alpha Pharmaceuticals has concentrated its efforts into producing and manufacturing herbal supplements and remedies. As a pharmaceutical company, all herbal supplements and health products manufactured by Omega Alpha Pharmaceuticals Inc. are done so following rigid standards and uncompromising quality. Omega Alpha Pharmaceuticals Inc. specializes in formulations for enhancing equine health and performance, using the finest natural ingredients available. For a list of the wide range of products for the optimum health and performance of humans, equines and pets, please visit www.oapharma.com.

About Equine Canada

Equine Canada is a member-based association that represents, promotes and services Canada's equine community and industry. Its core areas of activity involve sport, equine health and welfare, education and safety, governance and marketing, representation and communication. Equine Canada is recognized by Sport Canada, Agriculture and Agri-Food Canada, the International Equestrian Federation (FEI), the Canadian Olympic Committee and Canadian Coaching Association of Canada as the national organization representing equestrian sport and equine interests in Canada. For more information about Equine Canada, please visit www.equinecanada.ca.


Return »

Copyright © 2006
Omega Alpha Pharmaceuticals